VRDN - Financial Reports List - Viridian Therapeutics, Inc. - IntrinsicAlpha

Viridian Therapeutics, Inc. VRDN

Healthcare - Biotechnology - NASDAQ - US

$ 13.76

0 %

$ 1.12 B

Market Cap

-4.28

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-19.24%	-22.38%
Annual Report	FY	10-K	2024-12-31	-3.82%	-13.55%	-17.52%
Quarterly Report	Q3	8-K	2024-09-30	19.44%	-60.91%	-62.97%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-18.03%	-21.78%
Quarterly Report	Q1	8-K	2024-03-31	-26.53%	28.66%	22.87%
Quarterly Report	Q4	8-K	2023-12-31	-31.43%	-57.30%	-45.68%
Annual Report	FY	10-K	2023-12-31	-82.28%	-89.51%	-89.46%
Quarterly Report	Q3	8-K	2023-09-30	-93.97%	-70.06%	-71.98%
Quarterly Report	Q2	8-K	2023-06-30	-71.88%	-86.71%	-100.50%
Quarterly Report	Q1	8-K	2023-03-31	-54.63%	-166.88%	-179.94%

1